Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol.

MLA

Kong, Anthony, et al. “Phase I Trial of WEE1 Inhibition with Chemotherapy and Radiotherapy as Adjuvant Treatment, and a Window of Opportunity Trial with Cisplatin in Patients with Head and Neck Cancer: The WISTERIA Trial Protocol.” BMJ Open, vol. 10, no. 3, Mar. 2020, p. e033009. EBSCOhost, https://doi.org/10.1136/bmjopen-2019-033009.

APA

Kong, A., Good, J., Kirkham, A., Savage, J., Mant, R., Llewellyn, L., Parish, J., Spruce, R., Forster, M., Schipani, S., Harrington, K., Sacco, J., Murray, P., Middleton, G., Yap, C., & Mehanna, H. (2020). Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol. BMJ Open, 10(3), e033009. https://doi.org/10.1136/bmjopen-2019-033009

Chicago

Kong, Anthony, James Good, Amanda Kirkham, Joshua Savage, Rhys Mant, Laura Llewellyn, Joanna Parish, et al. 2020. “Phase I Trial of WEE1 Inhibition with Chemotherapy and Radiotherapy as Adjuvant Treatment, and a Window of Opportunity Trial with Cisplatin in Patients with Head and Neck Cancer: The WISTERIA Trial Protocol.” BMJ Open 10 (3): e033009. doi:10.1136/bmjopen-2019-033009.